drug

naftifine hydrochloride

Marketedupdated 2mo ago

by Legacy Pharma Solutions

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

Patent cliff

source: FDA Orange Book

first barrier falls

Jan 31, 2033

~6.6 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (6)

Jan 31, 2033formulationUS 10166205
Jan 31, 2033formulationUS 10166206
Jan 31, 2033formulationUS 10695303
Jan 31, 2033formulationUS 10729667
Jan 31, 2033formulationUS 8778365
Jan 31, 2033method-of-use (U-540)US 9161914

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

Trials studying naftifine hydrochloride

phase1Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pediscompletedn=42